Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
OPTIC logo — AI-powered drug discovery platform for rapid molecule screen...

OPTIC

AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validatio

Founded 2021 United States San Francisco, United States 271 employees Seed Total: $11.00M AI, Information Technology +2

General Information

Company Name OPTIC
Founded Year 2021
Location United States San Francisco, United States
Employees 271
Industries AI, Information Technology, SaaS +1
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with OPTIC. To contact OPTIC, visit bioptic.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OPTIC compare?

A PDF of OPTIC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OPTIC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OPTIC

OPTIC is revolutionizing the pharmaceutical sector with its AI-powered drug discovery platform, enabling rapid molecule screening and testing from target identification to lab validation. The company, founded in 2021, is leveraging cutting-edge AI to automate biotech R&D processes.

Originally conceived as an AI research team focused on developing high-performance similarity search algorithms, OPTIC has successfully expanded its proprietary technology's applicability across various industries such as blockchain and biotech. Headquartered in the United States, OPTIC operates under the umbrellas of AI, Information Technology, SaaS, and Web3.

The company attracted attention with a significant $11.00M Seed Round investment on July 20, 2022, backed by renowned investors like Pantera Capital, Kleiner Perkins, Flamingo DAO, Circle, Lattice Capital, Neon DAO, Polygon, OpenSea, Greylock, and CoinDCX Ventures. These strategic partnerships underscore OPTIC's potential in transforming AI-driven solutions for drug discovery.

Business keywords: AI-powered drug discovery, molecule screening, biotech R&D automation, target identification, lab validation, similarity search algorithms, blockchain analytics, NFT provenance, content identification engine, Web3

Services & Products

AI Intelligence for Pharma
Patent and Trial Monitoring
Global Deal Surveillance
AI-Powered Strategic Insights

Target Customers

BD&L Analysts Corporate Venture Arms CIOs and IT Leaders Regulatory Affairs Teams Legal Teams Biotech Consultancies CSOs R&D Heads

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $11.00M 10
Pantera Capital Kleiner Perkins Flamingo DAO
Pantera Capital, Kleiner Perkins +8
20 Jul 2022

OPTIC Alternatives & Competitors

View All Alternatives
OPTIC vs
StartUs Insights
StartUs Insights Austria

Discover Global Innovation at Your Fingertips | Get smarter, faster insights from 9M+ startups & 20K...

21 employees
AI, Analytics
Compare OPTIC vs StartUs Insights
OPTIC vs
IPRally
IPRally Finland

Less searching, more answers

Series A
56 employees
AI, Information Technology
Compare OPTIC vs IPRally
OPTIC vs
Statt
Statt United States

Statt is a global AI SaaS platform focused on surfacing mission critical policy, regulatory, and geo...

Seed
18 employees
AI, B2B
View all alternatives

FAQ About OPTIC

AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validatio
OPTIC was founded in 2021.
OPTIC is headquartered in San Francisco, United States.
OPTIC operates in AI, Information Technology, SaaS and Web3. Its work centres on AI-powered drug discovery, molecule screening, biotech R&D automation and target identification. Its customers include BD&L Analysts, Corporate Venture Arms and CIOs and IT Leaders.
OPTIC has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
OPTIC has approximately 271 employees.
OPTIC has completed 1 funding round, raising a total of $11.00M. The latest funding stage is Seed.
OPTIC offers: AI Intelligence for Pharma, Patent and Trial Monitoring, Global Deal Surveillance, AI-Powered Strategic Insights.
Top alternatives and competitors to OPTIC include StartUs Insights, IPRally, Statt , Novable, Dstor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OPTIC and StartUs Insights are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OPTIC, https://bouncewatch.com/company/optic, updated 17 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes